ActiTrexx GmbH


ActiTrexx, a designated spin-out of the University Medical Center Mainz, Germany, focuses on the development and commercialization of the cellular therapy ATreg for the treatment of patients after hematopoetic stem cell transplantation (HSCT) to prevent graft-versus-host disease (GvHD).

Get Involved with the Advanced Therapies Congress


To sponsor or exhibit

Ashlea Foster
+44 208 164 3032



To speak

Ila Dickinson
+44 207 092 1150